Literature DB >> 26699427

Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review.

Karl Hörmann1, Andreas Zimmer2.   

Abstract

Lipid nanosized emulsions or nanoemulsions (NE) are oil in water dispersions with an oil droplet size of about 200nm. This size of oil droplets dispersed in a continuous water phase is a prerequisite for the parenteral, namely intravenous administration. Many parenteral nutrition and drug emulsions on the market confirm the safe use of NE over years. Parenteral emulsions loaded with APIs (active pharmaceutical ingredients) are considered as drug delivery systems (DDS). DDS focuses on the regulation of the in vivo dynamics, such as absorption, distribution, metabolism, and extended bioavailability, thereby improving the effectiveness and the safety of the drugs. Using an emulsion as a DDS, or through the use of surface diversification of the dispersed oil droplets of emulsions, a targeted increase of the API concentration in some parts of the human body can be achieved. This review focuses on NE similar to the marketed once with no or only low amount of additional surfactants beside the emulsifier from a manufacturing point of view (technique, used raw materials).
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery system; Drug targeting; Emulsion; Ingredients; Intravenous; Manufacturing; Materials; Nanoemulsion; Parenteral

Mesh:

Substances:

Year:  2015        PMID: 26699427     DOI: 10.1016/j.jconrel.2015.12.016

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  32 in total

1.  A new alternative for intravenous lipid emulsion 20% w/w from superolein oil and its effect on lipid and liver profiles in an animal model.

Authors:  Mohd Haz Hairul Amran; Mohd Hanif Zulfakar; Mohd Fairuz Danik; Mohd Shakrie Palan Abdullah; Ahmad Fuad Shamsuddin
Journal:  Daru       Date:  2019-04-24       Impact factor: 3.117

2.  Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment.

Authors:  Yinxian Yang; Hailing Gao; Shuang Zhou; Xiao Kuang; Zhenjie Wang; Hongzhuo Liu; Jin Sun
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  Vitamin E-rich Nanoemulsion Enhances the Antitumor Efficacy of Low-Dose Paclitaxel by Driving Th1 Immune Response.

Authors:  Jun Ye; Wujun Dong; Yanfang Yang; Huazhen Hao; Hengfeng Liao; Bangyuan Wang; Xue Han; Yiqun Jin; Xuejun Xia; Yuling Liu
Journal:  Pharm Res       Date:  2017-03-21       Impact factor: 4.200

Review 4.  Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting.

Authors:  Jessica F Liu; Bian Jang; David Issadore; Andrew Tsourkas
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-06-26

Review 5.  CD44-Targeted Nanocarrier for Cancer Therapy.

Authors:  Prashant Kesharwani; Rahul Chadar; Afsana Sheikh; Waleed Y Rizg; Awaji Y Safhi
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

6.  Optical sensor arrays designed for guided manufacture of perfluorocarbon nanoemulsions with a non-synthetic stabilizer.

Authors:  Ryan Bardsley; Graeme Gardner; Hubert M Tse; Christopher A Fraker
Journal:  Acta Biomater       Date:  2021-09-24       Impact factor: 8.947

7.  Influence of process and formulation parameters on the preparation of solid lipid nanoparticles by dual centrifugation.

Authors:  Denise Steiner; Heike Bunjes
Journal:  Int J Pharm X       Date:  2021-06-05

8.  A Comprehensive Study of Drug Loading in Hollow Mesoporous Silica Nanoparticles: Impacting Factors and Loading Efficiency.

Authors:  Lanying Guo; Jiantao Ping; Jinglei Qin; Mu Yang; Xi Wu; Mei You; Fangtian You; Hongshang Peng
Journal:  Nanomaterials (Basel)       Date:  2021-05-14       Impact factor: 5.076

9.  A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis.

Authors:  Samuel Bonnet; Geoffrey Prévot; Stéphane Mornet; Marie-Josée Jacobin-Valat; Yannick Mousli; Audrey Hemadou; Mathieu Duttine; Aurélien Trotier; Stéphane Sanchez; Martine Duonor-Cérutti; Sylvie Crauste-Manciet; Gisèle Clofent-Sanchez
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

10.  Hybrid Theranostic Cubosomes for Efficient NIR-Induced Photodynamic Therapy.

Authors:  Urszula Bazylińska; Dominika Wawrzyńczyk; Julita Kulbacka; Giacomo Picci; Livia Salvati Manni; Stephan Handschin; Marco Fornasier; Claudia Caltagirone; Raffaele Mezzenga; Sergio Murgia
Journal:  ACS Nano       Date:  2022-03-25       Impact factor: 18.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.